- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Naxpar Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (80), financial health (90), director (90) and company-foundation signals.
- Operating for 22+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2024.
- Positive net worth.
- 5 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Naxpar Pharma
Naxpar Pharma is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U52310MH2004PTC144449). Business overview includes Pharma (Drug Formulation & Development), incorporated on February 10, 2004 (22+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status.
- Location 104-107Bldg No 8 Jogani Ind Complex Chunabhatti, Mumbai, Maharashtra - 400022
- Website naxparlab.com
Financial Performance of Naxpar Pharma
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Naxpar Pharma (5)
Charges of Naxpar Pharma
| Lender | Amount | Status |
|---|---|---|
|
Hdfc Bank Limited
Creation Date: 30 Jun 2025 |
2.91 cr | Open |
|
Hdfc Bank Limited
Creation Date: 13 Dec 2023 |
14.16 cr | Open |
|
Hdfc Bank Limited
Creation Date: 25 Jul 2023 |
9.77 Lakh | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
